Withings
French maker of connected scales, watches, and BP monitors, now also running medical care programs.
Withings survives on regulatory clearances and patient enrollment that AI assistants can't copy, but its brand-new care-delivery business is weeks old and unproven.
Withings sells wearable devices like smartwatches and scales, plus software that hospitals and insurers use to monitor patients. The company is protected by government approvals (FDA clearances) and insurance reimbursement that took years to earn, which rivals like Apple cannot quickly copy, though Apple dominates consumer wearables and companies like Oura offer AI-powered health coaching that could chip away at Withings' consumer appeal. The real question is whether Withings' brand-new direct care delivery business, which launched just weeks ago, can actually sign up patients and get paid by insurance companies, because if it cannot, the company may have burned cash on an experiment that changes nothing.
Apple ships an FDA-cleared blood-pressure or glucose feature on Watch/ring by end of 2026. Would show Apple closing the regulatory gap Withings relies on.
Oura completes or withdraws its confidential US IPO filing. Signals capital and competitive intensity shifting in the wearables market.
- 66% of 2025 revenue from cleared medical devices
- 740,000+ patients enrolled in Health Solutions
- First full-year profitability ever in 2025
- Withings Medical care-delivery pivot is weeks old (launched July 2026) with no track record.
- Consumer hardware line lacks regulatory moat and faces well-funded AI-native rivals.
- All revenue, user, and profitability figures are self-reported with no independent audit found.
- Internally inconsistent headcount figures (400 vs 311) across company releases raise data-quality concerns.
- Apple could ship an FDA-cleared BP or glucose device and erode Withings' clinical-wearables niche.
| Rival | Direction | Evidence |
|---|---|---|
| Apple | contesting | Apple Watch overlaps on ECG/BP features but its health push stalled per Bloomberg, May 2026 |
| Oura | gaining on | Confidentially filed for US IPO and ranked most accurate sleep tracker by independent study, May 2026 |
| Fitbit (Google) | losing to | Google confirmed Fitbit halted new hardware development, August 2024 |
| Samsung | contesting | Galaxy Watch 8 ships with Google Gemini AI coaching, January 2026 |
- Is Withings profitable in 2025?
- Yes. Withings announced on June 30, 2026 that it achieved full-year profitability for 2025, the first time since founder Eric Carreel bought the company back from Nokia in May 2018, with revenue up roughly 90 percent since the buyback.
- Who owns Withings?
- Withings is privately owned and founder-controlled. Nokia bought it in 2016 for about 170 million euros, then co-founder Eric Carreel repurchased the business from Nokia in May 2018 for an undisclosed, reportedly much lower sum, returning it to independent ownership.
- Could AI replace Withings' products?
- Generic AI coaching layers like Google Gemini on Samsung watches and Oura's LLM advisor are commoditizing consumer health insights, but Withings' FDA/CE-MDR clearances, CMS ACCESS Model reimbursement status (April 2026), and 740,000+ enrolled patients as of mid-2026 form a regulatory moat AI alone cannot replicate quickly.
- Is Withings a safe company to join in 2026?
- Withings reports full-year 2025 profitability, a global team the company describes as roughly 400 people, and an expanding B2B Health Solutions business enrolling 740,000+ patients by mid-2026, though it also just launched an unproven care-delivery model (Withings Medical) in July 2026.
- Who is Withings' biggest competitor?
- Apple is the most direct incumbent threat via Apple Watch's overlapping ECG and blood pressure features, though Bloomberg reported in May 2026 that Apple's health push has stalled; Oura and Fitbit compete in wearables, with Oura confidentially filing for a US IPO around May 2026.
- What is Withings Medical?
- Withings Medical is a clinical-care service for Medicare-eligible patients that Withings launched July 8 to 9, 2026 under CMS's new ACCESS Model, moving the company beyond device sales into direct chronic-disease care delivery, a business model that is only weeks old and unproven.
- 2026-07-09Withings Medical clinical-care service launches under CMS ACCESS Model
- 2026-06-30Withings confirms first-ever full-year profitability for 2025
- 2026-06-19Withings acquires Biosency, a respiratory remote-monitoring company
- 2026-06-02Withings launches lower-priced BodyFit body-composition scale
- 2026-04-20Withings accepted into CMS ACCESS Model Medicare pilot
- 2025-11FDA clears Withings BeamO multi-function thermometer
- 2025-06Withings Intelligence AI insights feature launches in beta
- 2018-05Eric Carreel repurchases Withings from Nokia
- 2016-04Nokia acquires Withings for about 170 million euros
- 2008Withings founded by Eric Carreel, Cedric Hutchings, Fred Potter
- The Buyback Pays Off... Withings Confirms Full Year Profitability for 2025 (2026-06-30)
- Withings (2026-06-16)
- Who Owns Withings Company? (2026-03-17)
- Withings_US_Corporate Story_2026
- Withings Stock Price, Funding, Valuation... (2026-06-21)
- Revenue, Competitors, Alternatives (2022-04-19)
- Withings Achieves Profitability in 2025 (2026-07-13)
- Withings USA Press
- Withings UK
- Withings Accepted into CMS ACCESS Model (2026-04-20)
- Withings acquires Biosency (2026-06-19)
- Withings Launches Withings Medical (2026-07-09)